AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

13.55 -0.19 (-1.35%)

Delayed Quote Updated: 2:16 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 ↗

November 16, 2022

Upgrades

Via Benzinga

AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022

November 10, 2022

From AbCellera Biologics Inc.

Via Business Wire

Recap: AbCellera Biologics Q1 Earnings ↗

May 10, 2022

AbCellera Biologics (NASDAQ:ABCL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session ↗

November 10, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...

Via Benzinga

Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket ↗

November 10, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.

Via Benzinga

Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 10, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket ↗

November 09, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of...

Via Benzinga

AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

ABCL earnings call for the period ending September 30, 2022.

Via The Motley Fool

AbCellera Reports Q3 2022 Business Results

November 08, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Present at Upcoming Investor Conferences in November

November 04, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development

November 02, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022

October 11, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022

October 05, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Launches Second Phase of Global Headquarters Expansion to Advance Capabilities for Bringing New Medicines from Target to the Clinic

September 21, 2022

From AbCellera Biologics Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 02, 2022

We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

Coinbase, Trade Desk, H&R Block And Some Other Big Gainers From Wednesday ↗

August 11, 2022

U.S. stocks closed higher on Wednesday following the release of inflation data. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket ↗

August 10, 2022

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.

Via Benzinga

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session ↗

August 10, 2022

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

Via Benzinga

AbCellera Reports Q2 2022 Business Results

August 09, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients

August 03, 2022

From AbCellera Biologics Inc.

Via Business Wire

Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies

July 27, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022

July 12, 2022

From AbCellera Biologics Inc.

Via Business Wire

Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options

June 29, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Biologics's Return On Capital Employed Insights ↗

June 10, 2022

According to Benzinga Pro, during Q1, AbCellera Biologics (NASDAQ:ABCL) earned $168.57 million, a 181.2% increase from the preceding quarter. AbCellera Biologics also posted a total of $316.58 million...

Via Benzinga

Cramer Shares His Thoughts On Stem, Marvell Technology And More ↗

May 17, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology Inc (NASDAQ: MRVL) is the "best when it comes to 5G, the best in high-performance computing.

Via Benzinga

What 4 Analyst Ratings Have To Say About AbCellera Biologics ↗

May 11, 2022

Over the past 3 months, 4 analysts have published their opinion on AbCellera Biologics (NASDAQ:ABCL) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

AbCellera Reports Q1 2022 Business Results

May 10, 2022

From AbCellera Biologics Inc.

Via Business Wire

AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration

May 03, 2022

From AbCellera Biologics Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.